St. Jude Medical reports 'solid and uncontroversial' preliminary 4th-quarter sales of $1.44 billion despite setbacks with its Portico replacement heart valve.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1zhyvWl
Cap comentari:
Publica un comentari a l'entrada